The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 745K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

15 articles for Z Fan


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Targeting autophagy with small-molecule activators for potential therapeutic purposes.EBI
Sichuan University
Design, Synthesis, and Biological Evaluation of Potent and Selective PROTAC Degraders of Oncogenic KRASG12D.EBI
Shanghai Institute of Materia Medica
Modulators for palmitoylation of proteins and small molecules.EBI
Hebei University
Benzothiazole derivatives as histone deacetylase inhibitors for the treatment of autosomal dominant polycystic kidney disease.EBI
Xuzhou Medical University
Synthesis and Biological Evaluation of β-Lactam Derivatives Targeting Speckle-Type POZ Protein (SPOP).EBI
Nanjing University of Chinese Medicine
Discovery of a novel 1H-pyrazole- [3,4-b] pyridine-based lysine demethylase 5B inhibitor with potential anti-prostate cancer activity that perturbs the phosphoinositide 3-kinase/AKT pathway.EBI
Zhengzhou University
Discovery of a Potent, Cooperative, and Selective SOS1 PROTAC ZZ151 with In Vivo Antitumor Efficacy in KRAS-Mutant Cancers.EBI
Shanghai Institute of Materia Medica
Strategies for Targeting Serine/Threonine Protein Phosphatases with Small Molecules in Cancer.EBI
China Pharmaceutical University
Discovery of the First-in-Class Agonist-Based SOS1 PROTACs Effective in Human Cancer Cells Harboring Various KRAS Mutations.EBI
Shanghai Institute of Materia Medica
Multifunctional agents based on benzoxazolone as promising therapeutic drugs for diabetic nephropathy.EBI
Beijing Institute of Technology
Dihydrobenzoxazinone derivatives as aldose reductase inhibitors with antioxidant activity.EBI
Beijing Institute of Technology
Designing of acyl sulphonamide based quinoxalinones as multifunctional aldose reductase inhibitors.EBI
Beijing Institute of Technology
Discovery and structure-activity relationship of novel diphenylthiazole derivatives as BTK inhibitor with potent activity against B cell lymphoma cell lines.EBI
Nankai University
Chemical compoundsBDB
Astrazeneca
Inhibition of carbonic anhydrase II by steroidal and non-steroidal sulphamates.BDB
St. Mary'S Hospital